Amgen’s Bold Ambition: To Halve Cardiovascular Events in the U.S. by 2030

Cardiovascular disease is a leading public health crisis in the United States, with someone experiencing a heart attack or stroke every 40 seconds. High levels of LDL cholesterol (LDL-C) are a main culprit for cardiovascular events, and lowering these levels can reduce the risk of heart attack and stroke.